Overview
This is a research blend, sold here as a vial of lyophilized powder combining two individually studied peptides: BPC-157 (5mg) and TB-500 (5mg). Each component has its own distinct chemical identity and body of preclinical literature, summarized below rather than as a single compound — see each peptide's own reference page (linked at the bottom) for its full identifiers and research context.
Chemical identifiers
| Peptide | CAS number | Molecular formula | Molar mass |
|---|---|---|---|
| BPC-157 (5mg) | 137525-51-0 | C62H98N16O22 | 1419.55 g/mol |
| TB-500 (5mg) | 885340-08-9 | C38H68N10O14 | 889.02 g/mol |
See each peptide's own reference page — linked below — for full identifiers and sourcing.
Molecular structure
BPC-157
CID 9941957
TB-500
CID 62707662
Studied in the research literature for
General topic areas each component appears in published preclinical/animal research — not a statement of confirmed outcomes, and not applicable to human use.
- Preclinical models of gastrointestinal tissue repair (BPC-157)
- Tendon, ligament, and muscle healing models (BPC-157, TB-500)
- Angiogenesis (blood vessel formation) studies (BPC-157, TB-500)
- Cell-migration and actin-binding mechanism research (TB-500)
Storage & handling
- Store lyophilized (powder) vials at -20°C, protected from light.
- Once reconstituted for laboratory use, keep refrigerated at 2–8°C.
- Avoid repeated freeze-thaw cycles, which can degrade peptide integrity.
- Handle in accordance with your institution's standard laboratory safety practices.
Related
View this product in the catalog · View Certificate of Analysis · BPC-157 reference page · TB-500 reference page
